Evergreen Nephrology Achieves $40 Million Medicare Savings in Kidney Care
Evergreen Nephrology, an influential entity in value-based kidney care, has accomplished a major milestone by generating over $40 million in Medicare savings through its participation in the Center for Medicare & Medicaid Innovation (CMMI) Kidney Care Choices (KCC) program for 2024. Based in Nashville, the organization has effectively illustrated that patient-centered, coordinated kidney care can enhance patient outcomes while simultaneously lowering healthcare costs.
The company worked alongside nephrologists nationwide, achieving the second highest ranking among Kidney Contracting Entities (KCEs) for net savings throughout the country. Evergreen's affiliated provider organizations were among the top ten in the program, showcasing the company's pivotal role in equipping nephrologists with essential tools and support necessary for delivering quality care to those with chronic kidney disease (CKD). This collaboration resulted in fewer health complications, improved disease management, and a more holistic care experience for patients.
Heather Trafton, CEO of Evergreen Nephrology, stated, "These results show what's possible when nephrologists are supported with the right tools, data, and care teams to better manage kidney disease." Trafton stressed the importance of collaborative efforts in promoting patient health and ensuring the sustainability of kidney care.
The KCC program is a voluntary Medicare initiative aimed at enhancing care for patients with stage 4 and 5 CKD by encouraging early interventions, superior care coordination, and improved outcomes. The financial report for the latest performance year emphasized the effectiveness of Evergreen and its partners under the KCC model.
Evergreen Nephrology closely collaborates with participating nephrologists to drive substantial improvements in patient care. The organization effectively scales its value-based kidney care approach and provides comprehensive resources to tackle challenges, integrating multi-disciplinary elements into care plans to improve patient experiences.
Dr. Tom Watson, Medical Director of Nephrology Associates, P.C. of Alabama and President of the Evergreen Physicians Leadership Council, remarked, "Through our partnership with Evergreen, we've been able to better support patients with complex kidney disease, helping them stay healthier longer and avoid unnecessary complications," highlighting the transformational impact on their care delivery.
Evergreen Nephrology's efforts align with its mission to support individuals with chronic and end-stage kidney disease by addressing comprehensive well-being needs and enhancing overall patient care experiences. Operating across 24 states with a network exceeding 1,000 providers, Evergreen is committed to delivering personalized, value-based care for empowering positive health outcomes. For further information, visit their website or LinkedIn.